1 well as various aberrantly glycosylated IgA1 myeloma proteins.

2 wo IgA1 myeloma proteins but not to two IgA2 myeloma proteins.

3 , and single chain Fv (scFv) of more than 50 myeloma proteins and monoclonal antibodies (mAb) have be

4 ermined by reactivity with PC-specific mouse myeloma proteins and monoclonal antibodies.

5  as the human C-reactive protein, a class of myeloma proteins and PAF receptors.

6  with a response included 7 patients in whom myeloma protein became undetectable and 12 in whom myelo

7 ecretory immunoglobulin A (IgA) and two IgA1 myeloma proteins but not to two IgA2 myeloma proteins.

8 e region from a naturally Gal-deficient IgA1 myeloma protein have been analyzed by 9.4 tesla Fourier

9  assessed on the basis of a reduction of the myeloma protein in serum or Bence Jones protein in urine

10  constant [Ka] = 0.77 x 10(7) M(-1)) for the myeloma protein M315.

11  chain framework regions were from the human myeloma protein NEW, and the light chain framework regio

12 umns linked to a panel of cationic human IgG myeloma proteins positive for anti-DNA Id markers 16/6,

13 lls not only recognized and lysed autologous myeloma protein-pulsed DCs, they also killed autologous

14                                        A 25% myeloma protein reduction was obtained in 37% of patient

15 a protein became undetectable and 12 in whom myeloma protein was detectable only by immunofixation.

16 rom a naturally Gal-deficient polymeric IgA1 myeloma protein were analyzed by electron capture dissoc

17 alNAc was determined by reactivity with IgA1 myeloma proteins with enzymatically removed N-acetylneur